Acrivon Therapeutics, Inc. (ACRV): SC 13G/A filed Feb 13, 2024

Form type

SC 13G/A

Filing date

Feb 13, 2024

Accession number

0000908834-24-000055

Filer

Acrivon Therapeutics, Inc. (CIK 1781174)